Brodeur Gm
Impact in
- Neurology top 1%
- Neuroblastoma Research and Treatments
- Neurofibromatosis and Schwannoma Cases
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 16
- Neuroblastoma Research and Treatments 16
-
- 14-3-3 protein interactions 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- Seeger Rc (7 shared papers)Evans Ae (2 shared papers)M Favrot (2 shared papers)Victoria Castel (1 shared paper)Frank Berthold (1 shared paper)Jon Pritchard (1 shared paper)Carlsen Nl (1 shared paper)F Hedborg (1 shared paper)
- Journals
- PubMed (19 papers)
- Partner nations
- United States
In The Last Decade
Brodeur Gm
19 papers receiving 933 citations
Peers
Comparison fields: 5 of 47
- Neurology 805
- Cancer Research 199
- Molecular Biology 329
- Oncology 119
- Genetics 102
Countries citing papers authored by Brodeur Gm
This map shows the geographic impact of Brodeur Gm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brodeur Gm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brodeur Gm more than expected).
Fields of papers citing papers by Brodeur Gm
This network shows the impact of papers produced by Brodeur Gm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brodeur Gm. The network helps show where Brodeur Gm may publish in the future.
Co-authors
The 25 scholars most cited alongside Brodeur Gm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. | 1994 | 368 |
| 2 | Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. | 1987 | 155 |
| 3 | Biological classification of cell lines derived from human extra-cranial neural tumors. | 1988 | 79 |
| 4 | International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. | 1988 | 73 |
| 5 | Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. | 1988 | 68 |
| 6 | Neuroblastoma: clinical significance of genetic abnormalities. | 1990 | 43 |
| 7 | Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas. | 1988 | 38 |
| 8 | Molecular pathology of human neuroblastomas. | 1994 | 20 |
| 9 | The involvement of oncogenes and suppressor genes in human neoplasia. | 1987 | 15 |
| 10 | Characterization of human neuroblastoma cell lines that lack N-myc gene amplification. | 1988 | 12 |
| 11 | Histochemical demonstration of an increase in acetylcholinesterase in established lines of human and mouse neuroblastomas by nerve growth factor. | 1976 | 12 |
| 12 | Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation. | 1986 | 10 |
| 13 | Clinical significance of genetic rearrangements in human neuroblastomas. | 1989 | 9 |
| 14 | Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines. | 1994 | 9 |
| 15 | Screening for neuroblastoma (NB) in North America: the Quebec Project. | 1994 | 7 |
| 16 | Multiple defects of the nerve growth factor receptor in human neuroblastomas. | 1991 | 6 |
| 17 | N-myc protein expression by neuroblastoma cells that have metastasized to bone marrow. | 1988 | 6 |
| 18 | Characterization of the region of consistent deletion within 1p36 in neuroblastomas. | 1994 | 6 |
| 19 | Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification. | 1994 | 3 |
About Brodeur Gm
Brodeur Gm is a scholar working on Neurology, Molecular Biology, Cancer Research, Pharmacology and Epidemiology, having authored 19 papers that have together received 939 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (16 papers), Cancer, Hypoxia, and Metabolism (2 papers), Gestational Trophoblastic Disease Studies (1 paper), Genetic Syndromes and Imprinting (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper), Neuroendocrine Tumor Research Advances (1 paper), 14-3-3 protein interactions (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Neurology (805 citations), Cancer Research (199 citations), Molecular Biology (329 citations), Oncology (119 citations) and Genetics (102 citations). Brodeur Gm has collaborated with scholars based in United States. Frequent co-authors include Seeger Rc, Evans Ae, M Favrot, Victoria Castel, Frank Berthold, Jon Pritchard, Carlsen Nl, F Hedborg, J. Wasson and C. Patrick Reynolds. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.